Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?

from PharmacoEconomics at http://bit.ly/2lq7VaR on June 20, 2018 at 07:31PM Abstract Evidence from randomised controlled trials (RCTs) is used to support regulatory approval and reimbursement decisions. I discuss how these decisions are typically made and argue that the amount of sample data and regulatory authorities’ concerns over multiplicity are irrelevant when making reimbursement decisions. Decision […]